41 reports

MARKET ##.

  • Cholesterol
  • APAC
  • Japan
  • United States
  • World

Cholesterol Test Volume and Diagnostics Sales Forecasts by Market Segment Germany: LDL Cholesterol Test Volume and Diagnostics Sales Forecasts by Market Segment Italy: LDL Cholesterol Test Volume and Diagnostics Sales Forecasts by Market Segment Japan: LDL

  • Cholesterol
  • Hospital
  • Japan
  • United States
  • Forecast

Cholesterol Test Volume and Diagnostics Sales Forecasts by Market Segment Germany: Cholesterol Test Volume and Diagnostics Sales Forecasts by Market Segment Italy: Cholesterol Test Volume and Diagnostics Sales Forecasts by Market Segment Japan: Cholesterol Test Vo

  • Cholesterol
  • Chronic Disease
  • Diagnostics
  • Forecast

Cholesterol Direct Test Volume and Diagnostics Sales Forecasts by Market Segment Germany: LDL Cholesterol Direct Test Volume and Diagnostics Sales Forecasts by Market Segment Italy: LDL Cholesterol Direct Test Volume and Diagnostics Sales Forecasts by Market Segment Japan:

  • Cholesterol
  • Hospital
  • Japan
  • United States
  • Forecast

Cholesterol Test Volume and Sales Forecasts 2021: US, Europe, Japan--Hospitals, Commercial Labs, POC Locations List of Tables France: Cholesterol Test Volume and Diagnostics Sales Forecasts by Market Segment Germany: Cholesterol Test Volume and Diagnostics Sales Forecasts

  • Cholesterol
  • Chronic Disease
  • Japan
  • United States
  • Forecast
  • CHOLESTEROL ABSORPTION INHIBITORS
  • GLOBAL CHOLESTEROL ABSORPTION INHIBITORS MARKET 2016-2021 ($ MILLIONS)

As cholesterol disorder is one of the major causes for CVDs, patients try to strictly adhere to cholesterol maintaining drugs to avoid the occurrence of CVD.

  • Cardiovascular Disease
  • Cholesterol
  • Lipid Modifying Drug
  • Statins
  • AstraZeneca PLC
  • POC Cholesterol Testing
  • POC Cholesterol Self-Testing

Figure ##-## Percent of U. S.

  • Cholesterol
  • Point Of Care Testing
  • Abaxis, Inc.
  • Alere Inc.
  • PTS DIAGNOSTICS
  • Growing demand from emerging markets
  • Identifying factors impacting market growth

High blood cholesterol levels are highly prevalent and one of the leading causes of cardiovascular diseases among consumers worldwide.

  • Cholesterol
  • World
  • Forecast
  • Archer Daniels Midland Company
  • Cargill Inc.
  • PRESENTS THE CHOLESTEROL SYNTHESIS PATHWAY, HIGHLIGHTING THE MECHANISM OF ACTION OF STATINS.
  • DYSLIPIDEMIA: FREDRICKSON CLASSIFICATION SYSTEM

PLOS ONE; ##(##): ##-##.

  • Cholesterol
  • AstraZeneca PLC
  • Cerenis
  • Merck & Co., Inc.
  • The Medicines Company

Cholesterol Test Volume and Diagnostics Sales Forecasts by Market Segment Germany: Cholesterol Test Volume and Diagnostics Sales Forecasts by Market Segment Italy: Cholesterol Test Volume and Diagnostics Sales Forecasts by Market Segment Japan: Cholesterol Test Vo

  • Cholesterol
  • France
  • Germany
  • Italy
  • Forecast

MARKET ##.

  • Cholesterol
  • APAC
  • United States
  • World
  • Company Financials
  • Risk Factors and Comorbidities for Dyslipidemia
  • Executive Summary

Plos One; ##(##): ##-##.

  • Cholesterol
  • China
  • Germany
  • United States
  • Forecast
  • CHOLESTEROL TESTING SERVICES MARKET
  • CHOLESTEROL TESTING/CHOLESTEROL SCREENING SERVICES MARKET, BY TYPE OF CUSTOMER

LabCorp is one of the leading players in the cholesterol testing services market.

  • Cholesterol
  • North America
  • United States
  • Market Size
  • OPKO Health, Inc.
  • NOV 13, 2014: GALMED PHARMACEUTICALS ANNOUNCES FIRST ADMINISTRATION OF ARAMCHOL IN ITS PHASE IIA TRIAL FOR THE TREATMENT OF CHOLESTEROL GALLSTONES
  • Aramchol - Drug Profile

ATP Binding Cassette Sub Family A Member ## (ATP Binding Cassette Transporter ## or ABC ## or ATP Binding Cassette ## or Cholesterol Efflux Regulatory Protein or ABCA##) Overview ATP-binding cassette transporter (ABCA##, cholesterol efflux regulatory p

  • Cholesterol
  • United States
  • Company
  • Product Initiative
  • Galmed Pharmaceuticals Ltd.

The others segment encompasses market analysis of combination drug therapies such as Advicor, Vytorin, and Caduet, as well as cholesterol inhibitor drugs.

  • Cholesterol
  • Therapy
  • United States
  • Company Financials
  • Market Size
  • Jun 04, 2014: Recently Published Independent Research Supports the Importance of Reverse Cholesterol Transport on NASH Pathogenesis
  • Nov 13, 2014: Galmed Pharmaceuticals Announces First Administration of Aramchol in its Phase IIa Trial for the Treatment of Cholesterol Gallstones

ATP Binding Cassette Sub Family A Member ## (ATP Binding Cassette Transporter ## or ABC ## or ATP Binding Cassette ## or Cholesterol Efflux Regulatory Protein or ABCA##) Overview ATP-binding cassette transporter (ABCA##, cholesterol efflux regulatory p

  • Cholesterol
  • United States
  • Company
  • Product Initiative
  • Galmed Pharmaceuticals Ltd.
  • There was a significant increase in cholesterol efflux in dalcetrapib-treated AA population, but not the GG genotype
  • JUL 18, 2016: DALCOR DALCETRAPIB DEMONSTRATES GENOTYPE-DEPENDENT EFFECTS ON CHOLESTEROL EFFLUX AND INFLAMMATION IN DATA PUBLISHED BY THE MONTREAL HEART INSTITUTE IN CIRCULATION: CARDIOVASCULAR GENETICS

The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ##, ## and ## respectively.

  • Cardiology
  • Cardiovascular Disease
  • Cholesterol
  • Hospital
  • Pfizer Inc.
  • There was a significant increase in cholesterol efflux in dalcetrapib-treated AA population, but not the GG genotype
  • JUL 18, 2016: DALCOR DALCETRAPIB DEMONSTRATES GENOTYPE-DEPENDENT EFFECTS ON CHOLESTEROL EFFLUX AND INFLAMMATION IN DATA PUBLISHED BY THE MONTREAL HEART INSTITUTE IN CIRCULATION: CARDIOVASCULAR GENETICS

The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ##, ## and ## respectively.

  • Cardiology
  • Cardiovascular Disease
  • Cholesterol
  • Therapy
  • Pfizer Inc.
  • CHOLESTEROL POP TEST - PRODUCT DESCRIPTION
  • CHOLESTEROL POP TEST - PRODUCT STATUS

Akers Bio' s Tri-Cholesterol " Check" test is the only combined rapid test which provides an estimate of a person' s Total cholesterol as well as their High Density Lipoprotein (" HDL" ) cholesterol levels - their ' good cholesterolx

  • Cholesterol
  • Clinical Trial
  • Infectious Disease
  • Point Of Care Testing
  • Grifols, S.A.
  • Nov 03, 2009: FDA Turns Down Merck's Application For Combo Cholesterol Pill Involving Lipitor
  • Mar 27, 2007: Merck And Schering To Develop Zetia/Lipitor Combo As Focus On Reducing Bad Cholesterol Returns

Liptruzet contains ezetimibe, an efficacious LDL cholesterol lowering therapy, and atorvastatin, currently one of the most widely prescribed statins in the US.

  • Cholesterol
  • Lipid Modifying Drug
  • United States
  • Product Initiative
  • Merck & Co., Inc.
  • Clinical Trial profile. 16 Trial Title
  • Clinical Trial profile. 75 Trial Title

The prominent features of this report are - ##.

  • Cholesterol
  • Pharmaceutical
  • Therapy
  • World
  • Product Initiative
  • Nov 03, 2009: FDA Turns Down Merck's Application For Combo Cholesterol Pill Involving Lipitor
  • Mar 27, 2007: Merck And Schering To Develop Zetia/Lipitor Combo As Focus On Reducing Bad Cholesterol Returns

Liptruzet contains ezetimibe, an efficacious LDL cholesterol lowering therapy, and atorvastatin, currently one of the most widely prescribed statins in the US.

  • Cholesterol
  • Lipid Modifying Drug
  • United States
  • World
  • Product Initiative
  • Aug 11, 2017: Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
  • Nov 07, 2017: Esperion Provides Bempedoic Acid Franchise Development Program Updates; Reports Third Quarter 2017 Financial Results

Inhibition of Niemann-Pick C##-Like ## (NPC##L##) by ezetimibe results in reduced absorption of cholesterol from the gastrointestinal tract, thereby reducing delivery of cholesterol to the liver, which in turn upregulates LDL receptors.

  • Cholesterol
  • Therapy
  • United States
  • Deals & Alliance
  • Esperion Therapeutics, Inc.
  • Clinical Trial profile. 47 Trial Title

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Cholesterol
  • Obesity
  • Pathology
  • World
  • Product Initiative
  • Clinical Trial profile. 1547 Trial Title
  • Clinical Trial profile. 852 Trial Title

Hoffmann-La Roche Ltd ## ATP Binding Cassette Sub Family A Member ## (ATP Binding Cassette Transporter ## or ABC ## or ATP Binding Cassette ## or Cholesterol Efflux Regulatory Protein or ABCA##) Activator ATP Binding Cassette Sub Family A Member

  • Cholesterol
  • Clinical Trial
  • Lipid Modifying Drug
  • Pharmaceutical
  • World
  • CSL LIMITED
  • adverse cardiovascular event (MACE) defined as cardiovascular death, myocardial infarction (MI), ischemic stroke and hospitalization for unstable angina.

As demonstrated in preclinical and Phase ## studies, CSL## elevates cholesterol efflux capacity, as well as additional steps in reverse cholesterol transport.

  • Cholesterol
  • Therapy
  • World
  • Product Initiative
  • Cerenis
  • SMALL MOLECULE TO ANTAGONIZE FARNESOID X RECEPTOR FOR DYSLIPIDEMIA - DRUG PROFILE
  • Research and Development Brief

THIS LEADS TO A DECREASE IN HEPATIC CHOLESTEROL LEVELS AND INCREASE IN UPTAKE OF LDL CHOLESTEROL.

  • Cardiovascular Disease
  • Cholesterol
  • Chronic Disease
  • Pharmaceutical
  • Amarin Corporation plc
  • Clinical Trial profile. 181 Trial Title
  • Clinical Trial profile. 15 Trial Title

## ## ## ## ## ## ## GlaxoSmithKline Plc ## ## ## ## ## ## ## Medpace Holdings Inc ## ## ## ## ## ## ## AbbVie Inc ## ## ## ## ## ## ## Ionis Pharmaceuticals Inc ## ## ## ## ## ## ## Novartis AG ## ## ## ## ## ## ## Solen

  • Cholesterol
  • Clinical Trial
  • Therapy
  • World
  • AstraZeneca PLC
  • CSL LIMITED
  • ARI-1778 - DRUG PROFILE

As demonstrated in preclinical and Phase ## studies, CSL## elevates cholesterol efflux capacity, as well as additional steps in reverse cholesterol transport.

  • Cholesterol
  • Therapy
  • World
  • Product Initiative
  • Cerenis
  • R&D Progress Research and Development Brief
  • Apolipoprotein E (APOE) - Featured News & Press Releases

Similarly, the Universities' portfolio in Preclinical and Discovery stages comprises ## and ## molecules, respectively.

  • Cholesterol
  • Therapy
  • United States
  • Product Initiative
  • LipimetiX Development LLC